|
ASX - By Stock
|
SPL |
Re:
Low Half Year cash balance
|
|
sarge17
|
3 |
626 |
0 |
17:52 |
| 17:52 |
ASX - By Stock
|
3
|
626
|
0
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL Chart
|
|
sarge17
|
111 |
23K |
0 |
12:00 |
| 12:00 |
ASX - By Stock
|
111
|
23K
|
0
|
|
|
ASX - By Stock
|
SPL |
Re:
Is it this week
|
|
sarge17
|
8 |
1.5K |
2 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
8
|
1.5K
|
2
|
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Becoming a substantial holder
|
|
sarge17
|
38 |
6.9K |
2 |
16/03/26 |
| 16/03/26 |
ASX - By Stock
|
38
|
6.9K
|
2
|
|
|
ASX - By Stock
|
IMM |
Re:
What now
|
|
sarge17
|
51 |
17K |
17 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
51
|
17K
|
17
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL: Beating the "Kryptonite" – Why the 18-month HER2 wait was worth it
|
|
sarge17
|
22 |
4.6K |
0 |
15/03/26 |
| 15/03/26 |
ASX - By Stock
|
22
|
4.6K
|
0
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-004 to be discontinued following futility analysis
|
|
sarge17
|
288 |
103K |
20 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
288
|
103K
|
20
|
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-004 to be discontinued following futility analysis
|
|
sarge17
|
288 |
103K |
11 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
288
|
103K
|
11
|
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Becoming a substantial holder
|
|
sarge17
|
38 |
6.9K |
2 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
38
|
6.9K
|
2
|
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Becoming a substantial holder
|
|
sarge17
|
38 |
6.9K |
1 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
38
|
6.9K
|
1
|
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Becoming a substantial holder
|
|
sarge17
|
38 |
6.9K |
0 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
38
|
6.9K
|
0
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL: Beating the "Kryptonite" – Why the 18-month HER2 wait was worth it
|
|
sarge17
|
22 |
4.6K |
0 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
22
|
4.6K
|
0
|
|
|
ASX - By Stock
|
SPL |
Re:
Significant Radio Diagnostic program delay
|
|
sarge17
|
30 |
6.3K |
1 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
30
|
6.3K
|
1
|
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Becoming a substantial holder
|
|
sarge17
|
38 |
6.9K |
1 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
38
|
6.9K
|
1
|
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Becoming a substantial holder
|
|
sarge17
|
38 |
6.9K |
1 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
38
|
6.9K
|
1
|
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Ceasing to be a substantial holder
|
|
sarge17
|
3 |
595 |
3 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
3
|
595
|
3
|
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Becoming a substantial holder
|
|
sarge17
|
38 |
6.9K |
1 |
12/03/26 |
| 12/03/26 |
ASX - By Stock
|
38
|
6.9K
|
1
|
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Becoming a substantial holder
|
|
sarge17
|
38 |
6.9K |
1 |
11/03/26 |
| 11/03/26 |
ASX - By Stock
|
38
|
6.9K
|
1
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Acadia provides update on EU regulatory submission
|
|
sarge17
|
115 |
48K |
19 |
10/03/26 |
| 10/03/26 |
ASX - By Stock
|
115
|
48K
|
19
|
|
|
ASX - By Stock
|
NEU |
Re:
SBB
|
|
sarge17
|
54 |
15K |
1 |
09/03/26 |
| 09/03/26 |
ASX - By Stock
|
54
|
15K
|
1
|
|
|
ASX - By Stock
|
NEU |
Re:
SBB
|
|
sarge17
|
54 |
15K |
9 |
09/03/26 |
| 09/03/26 |
ASX - By Stock
|
54
|
15K
|
9
|
|
|
ASX - By Stock
|
NEU |
Re:
SBB
|
|
sarge17
|
54 |
15K |
19 |
08/03/26 |
| 08/03/26 |
ASX - By Stock
|
54
|
15K
|
19
|
|
|
ASX - By Stock
|
NEU |
Re:
SBB
|
|
sarge17
|
54 |
15K |
9 |
07/03/26 |
| 07/03/26 |
ASX - By Stock
|
54
|
15K
|
9
|
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
sarge17
|
17K |
8.9M |
19 |
07/03/26 |
| 07/03/26 |
ASX - By Stock
|
17K
|
8.9M
|
19
|
|
|
ASX - By Stock
|
NEU |
Re:
SBB
|
|
sarge17
|
54 |
15K |
13 |
06/03/26 |
| 06/03/26 |
ASX - By Stock
|
54
|
15K
|
13
|
|
|
ASX - By Stock
|
NEU |
Re:
SBB
|
|
sarge17
|
54 |
15K |
16 |
06/03/26 |
| 06/03/26 |
ASX - By Stock
|
54
|
15K
|
16
|
|
|
ASX - By Stock
|
SPL |
Re:
Significant Radio Diagnostic program delay
|
|
sarge17
|
30 |
6.3K |
2 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
30
|
6.3K
|
2
|
|
|
ASX - By Stock
|
SPL |
Re:
Significant Radio Diagnostic program delay
|
|
sarge17
|
30 |
6.3K |
1 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
30
|
6.3K
|
1
|
|
|
ASX - By Stock
|
SPL |
Re:
Significant Radio Diagnostic program delay
|
|
sarge17
|
30 |
6.3K |
0 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
30
|
6.3K
|
0
|
|
|
ASX - By Stock
|
SPL |
Re:
Perfect Storm": Starpharma’s Speculative Path to ASX 300 Re-Inclusion in 202
|
|
sarge17
|
4 |
1.2K |
1 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
4
|
1.2K
|
1
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Acadia confirms plan to request CHMP re-examination
|
|
sarge17
|
13 |
5.7K |
9 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
13
|
5.7K
|
9
|
|
|
ASX - By Stock
|
SPL |
Re:
Significant Radio Diagnostic program delay
|
|
sarge17
|
30 |
6.3K |
0 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
30
|
6.3K
|
0
|
|
|
ASX - By Stock
|
SPL |
Re:
Significant Radio Diagnostic program delay
|
|
sarge17
|
30 |
6.3K |
0 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
30
|
6.3K
|
0
|
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Acadia confirms plan to request CHMP re-examination
|
|
sarge17
|
13 |
5.7K |
7 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
13
|
5.7K
|
7
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL Chart
|
|
sarge17
|
111 |
23K |
0 |
02/03/26 |
| 02/03/26 |
ASX - By Stock
|
111
|
23K
|
0
|
|
|
ASX - By Stock
|
SPL |
Re:
Perfect Storm": Starpharma’s Speculative Path to ASX 300 Re-Inclusion in 202
|
|
sarge17
|
4 |
1.2K |
0 |
28/02/26 |
| 28/02/26 |
ASX - By Stock
|
4
|
1.2K
|
0
|
|
|
ASX - By Stock
|
NEU |
Re:
Competitors to Daybue
|
|
sarge17
|
79 |
44K |
4 |
27/02/26 |
| 27/02/26 |
ASX - By Stock
|
79
|
44K
|
4
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL Chart
|
|
sarge17
|
111 |
23K |
0 |
26/02/26 |
| 26/02/26 |
ASX - By Stock
|
111
|
23K
|
0
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL Chart
|
|
sarge17
|
111 |
23K |
1 |
26/02/26 |
| 26/02/26 |
ASX - By Stock
|
111
|
23K
|
1
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL Chart
|
|
sarge17
|
111 |
23K |
0 |
26/02/26 |
| 26/02/26 |
ASX - By Stock
|
111
|
23K
|
0
|
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
sarge17
|
1.8K |
944K |
19 |
26/02/26 |
| 26/02/26 |
ASX - By Stock
|
1.8K
|
944K
|
19
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL: Beating the "Kryptonite" – Why the 18-month HER2 wait was worth it
|
|
sarge17
|
22 |
4.6K |
1 |
25/02/26 |
| 25/02/26 |
ASX - By Stock
|
22
|
4.6K
|
1
|
|
|
ASX - By Stock
|
SPL |
Re:
Significant Radio Diagnostic program delay
|
|
sarge17
|
30 |
6.3K |
2 |
25/02/26 |
| 25/02/26 |
ASX - By Stock
|
30
|
6.3K
|
2
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL: Beating the "Kryptonite" – Why the 18-month HER2 wait was worth it
|
|
sarge17
|
22 |
4.6K |
2 |
25/02/26 |
| 25/02/26 |
ASX - By Stock
|
22
|
4.6K
|
2
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL: Beating the "Kryptonite" – Why the 18-month HER2 wait was worth it
|
|
sarge17
|
22 |
4.6K |
2 |
25/02/26 |
| 25/02/26 |
ASX - By Stock
|
22
|
4.6K
|
2
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL: Beating the "Kryptonite" – Why the 18-month HER2 wait was worth it
|
|
sarge17
|
22 |
4.6K |
0 |
24/02/26 |
| 24/02/26 |
ASX - By Stock
|
22
|
4.6K
|
0
|
|
|
ASX - By Stock
|
SPL |
Low Half Year cash balance
|
|
sarge17
|
3 |
626 |
1 |
24/02/26 |
| 24/02/26 |
ASX - By Stock
|
3
|
626
|
1
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL: Beating the "Kryptonite" – Why the 18-month HER2 wait was worth it
|
|
sarge17
|
22 |
4.6K |
0 |
24/02/26 |
| 24/02/26 |
ASX - By Stock
|
22
|
4.6K
|
0
|
|
|
ASX - By Stock
|
SPL |
Re:
SPL: Beating the "Kryptonite" – Why the 18-month HER2 wait was worth it
|
|
sarge17
|
22 |
4.6K |
3 |
23/02/26 |
| 23/02/26 |
ASX - By Stock
|
22
|
4.6K
|
3
|
|
|
ASX - By Stock
|
SPL |
Re:
Risk Tree - DEP Radiotheranostics
|
|
sarge17
|
5 |
942 |
2 |
23/02/26 |
| 23/02/26 |
ASX - By Stock
|
5
|
942
|
2
|
|